Lv1
30 积分 2025-03-05 加入
AI in small-molecule drug discovery: a coming wave?
16小时前
已完结
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
23天前
已完结
Psoriasis: a focus on upcoming oral formulations
1个月前
已完结
693 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)
1个月前
已完结
Evolving utility of apremilast in dermatological disorders for off-label indications
1个月前
已完结
Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands
1个月前
已完结
Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload
1个月前
已完结
Su1738 JNJ-77242113, AN ORAL PEPTIDE SELECTIVELY TARGETING THE IL-23 RECEPTOR, DEMONSTRATES PHARMACODYNAMIC ACTIVITY IN RAT AND HUMAN COLON TISSUE EXPLANTS FOLLOWING ORAL DOSING
1个月前
已完结
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
1个月前
已完结
Oral Delivery of Biologics for Precision Medicine
1个月前
已完结
皖公网安备34019202002308
